These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 7743462

  • 1. Platelet-activating factor antagonists.
    Koltai M, Braquet PG.
    Clin Rev Allergy; 1994; 12(4):361-80. PubMed ID: 7743462
    [No Abstract] [Full Text] [Related]

  • 2. Inflammatory membrane-derived lipids and their antagonists.
    Guinot P.
    Clin Rev Allergy; 1994; 12(4):305-7. PubMed ID: 7743459
    [No Abstract] [Full Text] [Related]

  • 3. Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Koltai M, Guinot P, Hosford D, Braquet PG.
    Adv Pharmacol; 1994; 28():81-167. PubMed ID: 8080821
    [No Abstract] [Full Text] [Related]

  • 4. Platelet-activating factor antagonists as therapeutic strategy in sepsis.
    Dhainaut JF, Mira JP, Brunet F.
    Prog Clin Biol Res; 1994; 388():277-93. PubMed ID: 7831364
    [No Abstract] [Full Text] [Related]

  • 5. [Platelet activating factor and platelet activating factor antagonists. New methods in asthma therapy?].
    Uhl D.
    Med Monatsschr Pharm; 1989 Jun; 12(6):170-2. PubMed ID: 2544789
    [No Abstract] [Full Text] [Related]

  • 6. [Platelet-activating factor antagonists and asthma].
    Wang YY, Li CL.
    Sheng Li Ke Xue Jin Zhan; 1992 Apr; 23(2):136-40. PubMed ID: 1329195
    [No Abstract] [Full Text] [Related]

  • 7. Preclinical and clinical pharmacology of platelet-activating factor receptor antagonists.
    Handley DA.
    Med Res Rev; 1990 Apr; 10(3):351-70. PubMed ID: 2164623
    [No Abstract] [Full Text] [Related]

  • 8. Recent development of platelet-activating factor antagonists.
    Shen TY, Hussaini I, Hwang SB, Chang MN.
    Adv Prostaglandin Thromboxane Leukot Res; 1989 Apr; 19():359-62. PubMed ID: 2546389
    [No Abstract] [Full Text] [Related]

  • 9. Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists.
    Houlihan WJ, Cheon SH, Parrino VA, Handley DA, Larson DA.
    J Med Chem; 1993 Oct 15; 36(21):3098-102. PubMed ID: 8230095
    [Abstract] [Full Text] [Related]

  • 10. Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.
    Curtis LD.
    Adv Exp Med Biol; 1996 Oct 15; 416():361-3. PubMed ID: 9131174
    [No Abstract] [Full Text] [Related]

  • 11. [The significance of platelet activating factor and its antagonists in bronchial asthma].
    Beume R, Kilian U.
    Med Klin (Munich); 1989 Jun 15; 84(6):286-93. PubMed ID: 2547143
    [No Abstract] [Full Text] [Related]

  • 12. Platelet-activating factor: antagonists, terminators, molecular mimics, and microbial opportunism.
    Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM.
    J Intern Med; 1996 Jun 15; 239(6):463-6. PubMed ID: 8656138
    [No Abstract] [Full Text] [Related]

  • 13. Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopenia.
    Meade CJ, Heuer H, Kempe R.
    Biochem Pharmacol; 1991 Mar 01; 41(5):657-68. PubMed ID: 1847810
    [No Abstract] [Full Text] [Related]

  • 14. Interspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist.
    Elder CA, Modi MW.
    Drug Metab Dispos; 1995 Jul 01; 23(7):776-8. PubMed ID: 7587967
    [No Abstract] [Full Text] [Related]

  • 15. ABT-299, a potent antagonist of platelet activating factor.
    Summers JB, Albert DH, Davidsen SK, Conway RG, Holms JH, Magoc TJ, Luo G, Tapang P, Rhein DA, Carter GW.
    Adv Prostaglandin Thromboxane Leukot Res; 1995 Jul 01; 23():475-7. PubMed ID: 7732895
    [No Abstract] [Full Text] [Related]

  • 16. Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor.
    Shen TY, Hussaini IM.
    Methods Enzymol; 1990 Jul 01; 187():446-54. PubMed ID: 2172742
    [No Abstract] [Full Text] [Related]

  • 17. [Platelet-activating factor (PAF) antagonists].
    Terasawa M.
    Tanpakushitsu Kakusan Koso; 1991 Feb 01; 36(3):379-87. PubMed ID: 1850862
    [No Abstract] [Full Text] [Related]

  • 18. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H, Imanishi N, Natsume Y, Morooka S.
    Eur J Pharmacol; 1994 Nov 15; 269(3):299-309. PubMed ID: 7895770
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists.
    Nguyên P, Petitfrère E, Potron G.
    Thromb Res; 1995 Apr 01; 78(1):33-42. PubMed ID: 7778064
    [Abstract] [Full Text] [Related]

  • 20. Effect of platelet-activating factor on platelets and vascular endothelium.
    Braquet P, Bourgain R, Mencia-Huerta JM.
    Semin Thromb Hemost; 1989 Apr 01; 15(2):184-96. PubMed ID: 2546255
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.